Author:
Zamboglou Constantinos,Bronsert Peter,Küsters Simon,Salm Natalie,Azèmar Marc,Brunner Thomas
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology Nuclear Medicine and imaging
Reference18 articles.
1. Akasbi Y, Arifi S, El Idrissi M, Shimi M, Boutayeb F, El Mrini A, El Mesbahi O (2012) Soft-tissue metastasis revealing a pancreatic adenocarcinoma: one case report and a review of literature. Pan Afr Med J 11:32
2. Badakhshi H, Grun A, Stromberger C, Budach V, Boehmer D (2013) Oligometastases: the new paradigm and options for radiotherapy. A critical review. Strahlenther Onkol 189:357–362
3. Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Cameron JL, Olino K, Schulick R, Winter J, Herman JM, Laheru D, Klein AP, Vogelstein B, Kinzler KW, Velculescu VE, Hruban RH (2009) SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Research 15:4674–4679
4. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. New Engl J Med 342:1350–1358
5. Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA (2011) Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. J Clin Oncol 29:3037–3043